This meeting took place in 2012
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
The Biology of Cytokines (Q1)
Organizer(s) Christopher A. Hunter, John J. O'Shea and Fiona M. Powrie
February 5—10, 2012
Keystone Resort • Keystone, CO USA
Abstract Deadline: Oct 5, 2011
Late Abstract Deadline: Nov 7, 2011
Scholarship Deadline: Oct 5, 2011
Early Registration Deadline: Dec 5, 2011
Sponsored by Novartis Institutes for BioMedical Research and Novo Nordisk A/S. Supported by an educational donation provided by Amgen.
Joint Meeting:
Th17 Cells in Health and Disease (Q2)
Summary of Meeting:
In the last decade, cytokine therapies have been included as the standard of care for the treatment of infectious disease and cancer, and cytokine antagonists have been deployed for the management of chronic inflammation. Many researchers in this field are interested in basic principles through which cytokines mediate communication with and between cells of the immune system. Others are interested in the contributions of cytokines and cytokine signaling to the development of, or protection from, a broad range of diseases including allergy, infectious diseases, cancer, atherosclerosis and autoimmunity. With the recognition that many of these pathways impact broadly on multiple conditions, the goal of the Keystone Symposia meeting on The Biology of Cytokines is to promote interaction between scientists who study the molecular mechanisms of cytokine function, signal transduction and gene expression, and scientists who study how cytokines work in vivo. We anticipate that this meeting will foster discussion aimed at translating this knowledge into novel therapies for human disease. Opportunities for interdisciplinary interaction will be significantly enhanced by the concurrent meeting on Th17 Cells in Health and Disease, which will share a keynote address and two plenary sessions with this meeting.
View Meeting Program
In the last decade, cytokine therapies have been included as the standard of care for the treatment of infectious disease and cancer, and cytokine antagonists have been deployed for the management of chronic inflammation. Many researchers in this field are interested in basic principles through which cytokines mediate communication with and between cells of the immune system. Others are interested in the contributions of cytokines and cytokine signaling to the development of, or protection from, a broad range of diseases including allergy, infectious diseases, cancer, atherosclerosis and autoimmunity. With the recognition that many of these pathways impact broadly on multiple conditions, the goal of the Keystone Symposia meeting on The Biology of Cytokines is to promote interaction between scientists who study the molecular mechanisms of cytokine function, signal transduction and gene expression, and scientists who study how cytokines work in vivo. We anticipate that this meeting will foster discussion aimed at translating this knowledge into novel therapies for human disease. Opportunities for interdisciplinary interaction will be significantly enhanced by the concurrent meeting on Th17 Cells in Health and Disease, which will share a keynote address and two plenary sessions with this meeting.
View Meeting Program
Scholarships/Awards
Keystone Symposia Future of Science Fund Scholarship Recipients
Sara C. Brass
Dartmouth COllege, USA
Marco Cardone
Food and Drug Administration, USA
James Harris
Monash University, Australia
National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients
Virginia Kocieda
Temple University - School of Medicine, USA
National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients
Chia-Lin Hsu
National Yang-Ming University, Taiwan
Marcel F. Nold
Monash University, Australia
Rachel Rosenstein
New York University, USA
Nathalie Schmitt
Baylor Institute for Immunology Research, USA
Wen-I Yeh
University of Florida, USA
